Hjem › Kardiovaskulær sygdom › Virginia › Arlington
Kardiovaskulær sygdom kliniske forsøg i Arlington, VA
13 studier for Kardiovaskulær sygdom søger deltagere på steder i og omkring Arlington (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
ELEVATE-HFpEF Clinical Study
Rekrutterer
- Inova Fairfax Hospital, Falls Church · 4 mi væk
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Carient Heart and Vascular LLC-Reston, Reston · 14 mi væk
- Carient Heart & Vascular - Manassas, Manassas · 22 mi væk
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- Seven Corners Medical Center, Falls Church · 4 mi væk
- Carient Heart and Vascular, Manassas · 22 mi væk
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RekruttererFase 3
- Virginia Heart, Falls Church · 4 mi væk
Product Surveillance Registry
RekruttererObservationsstudie
- Falls Church, Falls Church · 4 mi væk
- Fairfax, Fairfax · 11 mi væk
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RekruttererFase 3
- Clinical Trial Site, Arlington
- Clinical Trial Site, Falls Church · 4 mi væk
- Clinical Trial Site, Fairfax · 11 mi væk
- og 1 flere
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekrutterer
- Inova Fairfax Hospital, Fairfax · 11 mi væk
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Inova Fairfax Medical Campus, Falls Church · 4 mi væk
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RekruttererFase 3
- Inova Fairfax Hospital, Falls Church · 4 mi væk
- Virginia Heart, Falls Church · 4 mi væk
- Carient Heart and Vascular, Manassas · 22 mi væk
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekruttererFase 3
- Research Site, Falls Church · 4 mi væk
- Research Site, Fairfax · 11 mi væk
- Research Site, Manassas · 22 mi væk
- og 1 flere
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekruttererFase 3
- Virginia Heart, Falls Church · 4 mi væk
- Inova Cardiology - Fairfax, Fairfax · 11 mi væk
- Carient Heart and Vascular, Manassas · 22 mi væk
Global Paradise System US Post Approval Study
RekruttererObservationsstudie
- Inova Fairfax Hospital, Fairfax · 11 mi væk
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RekruttererFase 3
- Virginia Heart, Falls Church · 4 mi væk
Kardiovaskulær sygdom forsøg i andre byer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC29 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Atlanta, GA22 studier
- Cleveland, OH22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- San Francisco, CA18 studier
Andre studier i Arlington
- Ikke-småcellet lungecancer104 studier
- Metastatisk cancer53 studier
- Colorektal kræft52 studier
- Kræft (alle typer)48 studier
- Brystkræft46 studier
- Ægstockræft46 studier
- Lungecancer41 studier
- Livmoderslimhindekræft39 studier
- Bugspytkirtelkræft33 studier
- Pladecellekræft i hoved og hals26 studier
- Småcellet lungekræft23 studier
- Tripelnegativ brystkræft20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.